Boca Raton, FL -- (SBWIRE) -- 08/08/2013 -- StockFreak scours the market on a daily basis looking for the hottest penny stocks that may be the next big runners.StockFreak focuses on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks – Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX), Berkshire Hathaway Inc. (NYSE:BRK.B), Solta Medical Inc (NASDAQ:SLTM), Vringo, Inc. (NASDAQ:VRNG)
Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) opened the session at $1.46, remained amid the day range of $1.28 - $1.46, and closed the session at $1.35. The stock showed a negative performance of -8.16% in previous trading session. The stock gained a volume of 2.78 million shares and the average volume of the stock remained 1.40 million shares. Catalyst Pharmaceutical Partners, Inc. is a development-stage biopharmaceutical company. The Company is focused on the development and commercialization of prescription drugs targeting addiction diseases and disorders of the central nervous system with a focus on the treatment of addiction and epilepsy.
Has CPRX Found The Bottom and Ready To Move Up? Find Out Here
Berkshire Hathaway Inc. (NYSE:BRK.B) traded with volume of 2.77 million shares in the prior session and the average volume of the stock remained 3.27 million shares. The 52 week range of the stock remained $83.85 - $119.30. The stock showed a negative movement of -0.94% and closed its session at $116.80. The market capitalization of the stock remained 287.98 billion. Berkshire Hathaway Inc. (Berkshire) is a holding company owning subsidiaries engaged in a number of diverse business activities. The Company is engaged in the insurance businesses conducted on both a primary basis and a reinsurance basis, a freight rail transportation business and a group of utility.
Has BRK.B Found The Bottom And Ready To Gain Momentum? Find Out Here
Solta Medical Inc (NASDAQ:SLTM) exchanged 2.68 million shares and the average volume remained 499,877.00 shares. The stock dropped -10.36% and closed the session at $2.25. The beta of the stock remained 2.62 and the EPS of the stock remained -0.51. The shares outstanding of the stock remained 79.34 million. Solta Medical, Inc. designs, develops, manufactures and markets professional and consumer energy-based medical device systems for aesthetic applications. The Company's systems are cleared by the United States Food and Drug Administration (FDA) for dermatological procedures performed in the physician led, professional assist, and personal care markets.
Why Should Investors Buy SLTM After the Recent Fall? Just Go Here and Find Out
Vringo, Inc. (NASDAQ:VRNG) gained volume of 2.54 million shares, while the average volume remained 2.34 million shares. The stock advanced 0.88% and finished the session Wednesday at $3.43. The EPS of the stock remained -0.18. The one month of the stock was 12.09% and three month trend remained positive 16.27%.Vringo, Inc. (Vringo) is a development-stage company. The Company is engaged in developing software for mobile phones. It provides a platform, which allows users to create, download and share mobile entertainment content in the form of video ringtones for mobile phones.
Why Should Investors Buy VRNG After The Recent Gain? Just Go Here and Find Out
StockFreak scours the market on a daily basis looking for the hottest penny stocks that may be the next big runners. We strive to provide you with only the most opportunistic picks by pouring over mountains of data and charts. How often we send out our alerts is dependent on how often we find something worthwhile.
GENERAL NOTICE AND DISCLAIMER - PLEASE READ CAREFULLY THE FOLLOWING NOTICE AND DISCLAIMER MUST BE READ AND UNDERSTOOD AND YOU MUST AGREE TO THE TERMS CONTAINED THEREIN BEFORE USING THIS WEBSITE OR SUBSCRIBING TO OUR NEWSLETTER.
We are engaged in the business of advertising and promoting companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. Neither the owner of StockFreak.com nor any of its members, officers, directors, contractors or employees are licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed on StockFreak.com. It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. StockFreak.com makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website.
StockFreak.com has been retained by an unrelated third party to perform promotional and advertising services for a limited time with respect to the company we are profiling or discussing on this website and in exchange for such services has received cash compensation from such third party. Questions regarding this website may be sent to info@StockFreak.com.
Read Our Disclaimer at: http://www.stockfreak.com/disclaimer.html